Businessweek

Metabolix, Inc. reported unaudited consolidated financial results for the first quarter ended March 31, 2013. For the quarter, the company reported total revenue of $1.9 million compared to $39.3 million for the comparable quarter in 2012. The company reported a net loss of $6.8 million or $0.20 per share compared to net income of $28.8 million or $0.84 per share for the first quarter of 2012. Loss from operations was $6.785 million against income from operations of $28.823 million for the same period a year ago. The company's net cash used in operating activities was $8.5 million, which represents a $3.8 million decrease in cash usage from $12.3 million for the comparable quarter in 2012. Purchase of property and equipment was $64,000 against $148,000 for the same period a year ago. The $37.4 million decrease in revenue in first quarter 2013 was primarily related to the $38.9 million in deferred revenue the company realized related to the termination of the Telles joint venture in first quarter of 2012. Net cash used in operating activities was represents a planned increase in net cash usage of $1.2 million, which was mainly attributable to the timing of the accrued annual performance payments that the company pay in first quarter of each year.

Metabolix, Inc. announced that they will report Q1, 2013 results After-Market on May 08, 2013

Metabolix, Inc. announced that its researchers will make technical presentations at the ANTEC Conference being held April 22-25 in Cincinnati, Ohio. Metabolix researchers will present new data showing that its biobased PHA (polyhydroxyalkanoate) copolymers significantly improve the mechanical, performance and environmental characteristics of the commercially significant polymers polylactide (PLA) and polyvinyl chloride (PVC).

Metabolix, Inc., Q1 2013 Earnings Call, May 08, 2013

Metabolix, Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2012. For the quarter, the company’s total revenue was $1,397,000 against $439,000 a year ago. Loss from operations was $9,520,000 against $9,617,000 a year ago. Net loss was $9,516,000 or $0.28 basic and diluted per share against $9,603,000 or $0.28 basic and diluted per share a year ago. net cash used in operating activities was $7.3 million, which represents a planned increase in cash usage from $6.3 million during the third quarter of 2012 and is a decrease over the $8.6 million used during the comparable period of 2011. For the year, the company’s total revenue was $42,316,000 against $1,425,000 a year ago. Income from operations was $3,603,000 against loss of $38,861,000 a year ago. Net income was $3,630,000 or $0.11 basic and diluted per share against $38,785,000 or $1.24 basic and diluted per share a year ago. Net cash used in operating activities was $31,736,000 against $31,731,000 a year ago. Purchase of property and equipment was $392,000 against $895,000 a year ago. The year-over-year increase in revenue was primarily related to $38.9 million in deferred revenue that was recognized as a result of the termination of the Telles joint venture in February 2012. The company provided revenue guidance for 2013. The company do anticipates that product revenue will increase 2013 as the company continues to gain market acceptance for products, although there will be fluctuations from quarter-to-quarter.